<DOC>
	<DOCNO>NCT00290563</DOCNO>
	<brief_summary>This study design investigate whether new drug may offer safe effective treatment patient overactive bladder .</brief_summary>
	<brief_title>A Multicenter , Double-Blind , Randomized , Placebo-Controlled , Phase II Study MK0594 Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<criteria>Patients predominantly urge incontinence overactive bladder episode Patients must meet minimum eligibility requirement ( e.g. , average number micturitions/day ) base screen diary card History Diabetes insipidus , uncontrolled hyperglycemia hypercalcemia Lower urinary tract symptom associate benign prostatic hypertrophy Active current Urinary Tract Infections ( UTIs ) Surgery correct prolapse uterus stress incontinence</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>